The Valley Desk

Clinical trial reportEuropean journal of haematologyPublished

Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported Outcomes

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
European journal of haematology
Published
Subject terms
Humans; Multiple Myeloma; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Treatment Outcome; Quality of Life; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
39952901
PubMed Central ID
PMC11976685
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal